Alexandria Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $8.99M | Buy |
119,692
+3,024
| +3% | +$230K | 0.83% | 36 |
|
|
2021
Q2 | $9.07M | Buy |
116,668
+3,685
| +3% | +$274K | 0.84% | 38 |
|
|
2021
Q1 | $8.31M | Sell |
112,983
-975
| -0.9% | -$71.9K | 0.84% | 38 |
|
|
2020
Q4 | $8.89M | Sell |
113,958
-723
| -0.6% | -$55.3K | 0.94% | 27 |
|
|
2020
Q3 | $9.08M | Buy |
114,681
+1,194
| +1% | +$93.5K | 1.08% | 21 |
|
|
2020
Q2 | $8.37M | Sell |
113,487
-2,261
| -2% | -$170K | 1.09% | 19 |
|
|
2020
Q1 | $8.5M | Sell |
115,748
-10,907
| -9% | -$857K | 1.39% | 15 |
|
|
2019
Q4 | $11M | Buy |
126,655
+92
| +0.1% | +$7.56K | 1.47% | 15 |
|
|
2019
Q3 | $10.2M | Sell |
126,563
-1,294
| -1% | -$104K | 1.5% | 11 |
|
|
2019
Q2 | $10.2M | Sell |
127,857
-1,215
| -0.9% | -$93K | 1.46% | 11 |
|
|
2019
Q1 | $10.2M | Buy |
129,072
+3,826
| +3% | +$286K | 1.48% | 10 |
|
|
2018
Q4 | $9.13M | Buy |
125,246
+37,228
| +42% | +$2.63M | 1.48% | 12 |
|
|
2018
Q3 | $5.96M | Sell |
88,018
-193
| -0.2% | -$12.3K | 0.88% | 32 |
|
|
2018
Q2 | $5.11M | Buy |
88,211
+77,616
| +733% | +$4.38M | 0.77% | 36 |
|
|
2018
Q1 | $551K | Sell |
10,595
-17
| -0.2% | -$918 | 0.08% | 169 |
|
|
2017
Q4 | $570K | Buy |
10,612
+20
| +0.2% | +$1.11K | 0.08% | 172 |
|
|
2017
Q3 | $647K | Hold |
10,592
| – | – | 0.16% | 88 |
|
|
2017
Q2 | $648K | Buy |
10,592
+1
| +0% | +$61 | 0.16% | 87 |
|
|
2017
Q1 | $642K | Buy |
10,591
+61
| +0.6% | +$3.7K | 0.16% | 87 |
|
|
2016
Q4 | $592K | Sell |
10,530
-9,987
| -49% | -$584K | 0.15% | 91 |
|
|
2016
Q3 | $1.22M | Sell |
20,517
-4,925
| -19% | -$288K | 0.22% | 74 |
|
|
2016
Q2 | $1.4M | Sell |
25,442
-166
| -0.6% | -$8.84K | 0.25% | 79 |
|
|
2016
Q1 | $1.29M | Buy |
25,608
+7,796
| +44% | +$382K | 0.23% | 81 |
|
|
2015
Q4 | $898K | Sell |
17,812
-284
| -2% | -$14.3K | 0.23% | 84 |
|
|
2015
Q3 | $852K | Buy |
18,096
+2,201
| +14% | +$117K | 0.21% | 86 |
|
|
2015
Q2 | $874K | Buy |
15,895
+7,147
| +82% | +$401K | 0.19% | 87 |
|
|
2015
Q1 | $480K | Buy |
8,748
+1,019
| +13% | +$57.7K | 0.17% | 64 |
|
|
2014
Q4 | $419K | Buy |
7,729
+24
| +0.3% | +$1.34K | 0.16% | 70 |
|
|
2014
Q3 | $436K | Sell |
7,705
-3
| -0% | -$168 | 0.19% | 66 |
|
|
2014
Q2 | $425K | Sell |
7,708
-634
| -8% | -$34.6K | 0.18% | 68 |
|
|
2014
Q1 | $452K | Buy |
8,342
+7,140
| +594% | +$370K | 0.2% | 69 |
|
|
2013
Q4 | $57K | Buy |
1,202
+39
| +3% | +$1.78K | 0.02% | 180 |
|
|
2013
Q3 | $53K | Hold |
1,163
| – | – | 0.02% | 184 |
|
|
2013
Q2 | $52K | Buy |
+1,163
| New | +$51.9K | 0.03% | 187 |
|
Other funds holding MRK
Alexandria Capital's MRK Position: Q3 2021 in Review
Alexandria Capital increased its Merck (MRK) stake by 2.6% in Q3 2021, buying an estimated $230K and bringing the position to 119,692 shares worth $8.99M. The position accounts for 0.83% of the portfolio, ranked #36.
Alexandria Capital first reported a position in MRK in Q2 2013 and has held it in 34 quarters since. The position peaked at $11M in Q4 2019. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.
- Alexandria Capital held 119,692 shares of Merck worth $8.99M as of Q3 2021.
- Alexandria Capital bought 3,024 Merck shares in Q3 2021, an estimated $230K.
- Merck made up 0.83% of Alexandria Capital's portfolio in Q3 2021, its #36 holding.
- Alexandria Capital first reported a position in Merck in Q2 2013 and has held it in 34 quarters since.
- Alexandria Capital's Merck position peaked at $11M in Q4 2019.
- 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.
Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.